BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 19597012)

  • 1. Resistance to therapies for infection by Plasmodium vivax.
    Baird JK
    Clin Microbiol Rev; 2009 Jul; 22(3):508-34. PubMed ID: 19597012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chloroquine-resistant Plasmodium vivax, Brazilian Amazon.
    de Santana Filho FS; Arcanjo AR; Chehuan YM; Costa MR; Martinez-Espinosa FE; Vieira JL; Barbosa Md; Alecrim WD; Alecrim Md
    Emerg Infect Dis; 2007 Jul; 13(7):1125-6. PubMed ID: 18214203
    [No Abstract]   [Full Text] [Related]  

  • 3. Imported tertian malaria resistant to primaquine.
    Na DJ; Han JD; Cha DY; Song IK; Choi HW; Chung EA; Park CW; Choi JS
    Korean J Intern Med; 1999 Jul; 14(2):86-9. PubMed ID: 10461431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo therapeutic efficacy of chloroquine alone or in combination with primaquine against vivax malaria in Kolkata, West Bengal, India, and polymorphism in pvmdr1 and pvcrt-o genes.
    Ganguly S; Saha P; Guha SK; Das S; Bera DK; Biswas A; Kundu PK; Saha B; Ray K; Maji AK
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1246-51. PubMed ID: 23262997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance.
    Price RN; Douglas NM; Anstey NM
    Curr Opin Infect Dis; 2009 Oct; 22(5):430-5. PubMed ID: 19571748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analysis of primaquine tolerance in a patient with relapsing vivax malaria.
    Bright AT; Alenazi T; Shokoples S; Tarning J; Paganotti GM; White NJ; Houston S; Winzeler EA; Yanow SK
    Emerg Infect Dis; 2013 May; 19(5):802-5. PubMed ID: 23648098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis.
    Commons RJ; Simpson JA; Thriemer K; Humphreys GS; Abreha T; Alemu SG; AƱez A; Anstey NM; Awab GR; Baird JK; Barber BE; Borghini-Fuhrer I; Chu CS; D'Alessandro U; Dahal P; Daher A; de Vries PJ; Erhart A; Gomes MSM; Gonzalez-Ceron L; Grigg MJ; Heidari A; Hwang J; Kager PA; Ketema T; Khan WA; Lacerda MVG; Leslie T; Ley B; Lidia K; Monteiro WM; Nosten F; Pereira DB; Phan GT; Phyo AP; Rowland M; Saravu K; Sibley CH; Siqueira AM; Stepniewska K; Sutanto I; Taylor WRJ; Thwaites G; Tran BQ; Tran HT; Valecha N; Vieira JLF; Wangchuk S; William T; Woodrow CJ; Zuluaga-Idarraga L; Guerin PJ; White NJ; Price RN
    Lancet Infect Dis; 2018 Sep; 18(9):1025-1034. PubMed ID: 30033231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and treatment of Plasmodium vivax malaria.
    Baird KJ; Maguire JD; Price RN
    Adv Parasitol; 2012; 80():203-70. PubMed ID: 23199489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confirmed Plasmodium vivax Resistance to Chloroquine in Central Vietnam.
    Thanh PV; Hong NV; Van NV; Louisa M; Baird K; Xa NX; Peeters Grietens K; Hung le X; Duong TT; Rosanas-Urgell A; Speybroeck N; D'Alessandro U; Erhart A
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7411-9. PubMed ID: 26392501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of artemether-lumefantrine for the treatment of uncomplicated Plasmodium vivax malaria.
    Bassat Q
    PLoS Negl Trop Dis; 2011 Dec; 5(12):e1325. PubMed ID: 22216359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research progress on Plasmodium vivax chloroquine resistance].
    Li JY; Li Q; Fang Q
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2014 Jun; 26(3):326-31. PubMed ID: 25345166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of clinical efficacy and in vitro sensitivity of Plasmodium vivax to chloroquine in area along Thai Myanmar border during 2009-2010.
    Muhamad P; Ruengweerayut R; Chacharoenkul W; Rungsihirunrat K; Na-Bangchang K
    Malar J; 2011 Feb; 10():44. PubMed ID: 21324161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand.
    Vijaykadga S; Rojanawatsirivej C; Congpoung K; Wilairatana P; Satimai W; Uaekowitchai C; Pumborplub B; Sittimongkol S; Pinyorattanachote A; Prigchoo P
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):566-9. PubMed ID: 15689067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic responses of Plasmodium vivax malaria to chloroquine and primaquine treatment in northeastern Myanmar.
    Yuan L; Wang Y; Parker DM; Gupta B; Yang Z; Liu H; Fan Q; Cao Y; Xiao Y; Lee MC; Zhou G; Yan G; Baird JK; Cui L
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1230-5. PubMed ID: 25512415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis.
    Price RN; von Seidlein L; Valecha N; Nosten F; Baird JK; White NJ
    Lancet Infect Dis; 2014 Oct; 14(10):982-91. PubMed ID: 25213732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring the Efficacy of Chloroquine-Primaquine Therapy for Uncomplicated Plasmodium vivax Malaria in the Main Transmission Hot Spot of Brazil.
    Ladeia-Andrade S; Menezes MJ; de Sousa TN; Silvino ACR; de Carvalho JF; Salla LC; Nery OA; de Melo GNP; Corder RM; Rodrigues PT; Ferreira MU
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia.
    Sutanto I; Tjahjono B; Basri H; Taylor WR; Putri FA; Meilia RA; Setiabudy R; Nurleila S; Ekawati LL; Elyazar I; Farrar J; Sudoyo H; Baird JK
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1128-35. PubMed ID: 23254437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia.
    Yeshiwondim AK; Tekle AH; Dengela DO; Yohannes AM; Teklehaimanot A
    Acta Trop; 2010 Feb; 113(2):105-13. PubMed ID: 19835832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of relapsing Plasmodium vivax malaria.
    Chu CS; White NJ
    Expert Rev Anti Infect Ther; 2016 Oct; 14(10):885-900. PubMed ID: 27530139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chloroquine resistance in Plasmodium vivax.
    Baird JK
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4075-83. PubMed ID: 15504824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.